254 related articles for article (PubMed ID: 30135067)
1. Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in
Kelly E; Sharma D; Wilkinson CJ; Williams RSB
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135067
[TBL] [Abstract][Full Text] [Related]
2. Analysis of a novel diacylglycerol kinase from Dictyostelium discoideum: DGKA.
Ostroski M; Tu-Sekine B; Raben DM
Biochemistry; 2005 Aug; 44(30):10199-207. PubMed ID: 16042397
[TBL] [Abstract][Full Text] [Related]
3. The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.
Chang P; Orabi B; Deranieh RM; Dham M; Hoeller O; Shimshoni JA; Yagen B; Bialer M; Greenberg ML; Walker MC; Williams RS
Dis Model Mech; 2012 Jan; 5(1):115-24. PubMed ID: 21876211
[TBL] [Abstract][Full Text] [Related]
4. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure.
Eickholt BJ; Towers GJ; Ryves WJ; Eikel D; Adley K; Ylinen LM; Chadborn NH; Harwood AJ; Nau H; Williams RS
Mol Pharmacol; 2005 May; 67(5):1426-33. PubMed ID: 15687223
[TBL] [Abstract][Full Text] [Related]
5. Dictyostelium discoideum has a single diacylglycerol kinase gene with similarity to mammalian theta isoforms.
De La Roche MA; Smith JL; Rico M; Carrasco S; Merida I; Licate L; Côté GP; Egelhoff TT
Biochem J; 2002 Dec; 368(Pt 3):809-15. PubMed ID: 12296770
[TBL] [Abstract][Full Text] [Related]
6. Structure-function studies for the panacea, valproic acid.
Terbach N; Williams RS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465
[TBL] [Abstract][Full Text] [Related]
7. Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium.
Terbach N; Shah R; Kelemen R; Klein PS; Gordienko D; Brown NA; Wilkinson CJ; Williams RS
J Cell Sci; 2011 Jul; 124(Pt 13):2267-76. PubMed ID: 21652627
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid.
Xu X; Müller-Taubenberger A; Adley KE; Pawolleck N; Lee VW; Wiedemann C; Sihra TS; Maniak M; Jin T; Williams RS
Eukaryot Cell; 2007 Jun; 6(6):899-906. PubMed ID: 17435006
[TBL] [Abstract][Full Text] [Related]
9. The neuroprotective agent, valproic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium discoideum.
Boeckeler K; Adley K; Xu X; Jenkins A; Jin T; Williams RS
Eur J Cell Biol; 2006 Sep; 85(9-10):1047-57. PubMed ID: 16759735
[TBL] [Abstract][Full Text] [Related]
10. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
Li X; Ketter TA; Frye MA
J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
[TBL] [Abstract][Full Text] [Related]
11. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
12. A common mechanism of action for three mood-stabilizing drugs.
Williams RS; Cheng L; Mudge AW; Harwood AJ
Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of valproic acid and the prevalence of cancers in bipolar disorder patients in a Taiwanese population: An association analysis using the National Health Insurance Research Database (NHIRD).
Lin CC; Hsieh TC; Wu LS
J Affect Disord; 2018 May; 232():103-108. PubMed ID: 29481993
[TBL] [Abstract][Full Text] [Related]
14. Conserved valproic-acid-induced lipid droplet formation in Dictyostelium and human hepatocytes identifies structurally active compounds.
Elphick LM; Pawolleck N; Guschina IA; Chaieb L; Eikel D; Nau H; Harwood JL; Plant NJ; Williams RS
Dis Model Mech; 2012 Mar; 5(2):231-40. PubMed ID: 22003123
[TBL] [Abstract][Full Text] [Related]
15. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
Yokoyama S; Yasui-Furukori N; Nakagami T; Miyazaki K; Ishioka M; Tarakita N; Kubo K; Sugawara N; Shimoda K
Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992
[TBL] [Abstract][Full Text] [Related]
16. Valproate in bipolar disorder: the Canadian perspective.
Joffe RT
Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
[TBL] [Abstract][Full Text] [Related]
17. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
Isoherranen N; Yagen B; Bialer M
Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
[TBL] [Abstract][Full Text] [Related]
18. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
Reynolds MF; Sisk EC; Rasgon NL
Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of valproic acid reduced mortality in bipolar disorder patients in a Taiwanese population: An association analysis using the national health insurance research database (NHIRD).
Hsieh TC; Lin CC; Wu LS
J Psychiatr Res; 2022 May; 149():339-343. PubMed ID: 34785038
[TBL] [Abstract][Full Text] [Related]
20. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
Rapoport SI; Bosetti F
Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
